[Home]   [Full version]  

Welch Allyn AED-10 defibrillators recalled

Nov 07 ,Medicine & Health


The U.S. Food and Drug Administration announced the recall of Welch Allyn AED-10 automatic external defibrillators due to possibly defective circuit boards.

The FDA said the recalled defibrillators carried part numbers 970302E, 970308E, 970310E and 970311E.

The devices are used by emergency or medical personnel and by consumers to treat cardiopulmonary arrest. The devices analyze an unconscious patient's heart rhythm and automatically deliver an electrical shock, if needed, to restore normal heart rhythm.

The company said it discovered some of the recalled defibrillators might fail or produce an unacceptable delay in analyzing a patient's heart rhythm.

The company said it plans to replace all affected units.

Consumers with questions can contact Welch Allyn at 800-462-0777.

Copyright 2007 by United Press International

Related stories:

Defibrillators save lives, don't diminish quality of life
Implantable cardioverter-defibrillators (ICDs) reduce the risk of death from sudden cardiac arrest (SCA) among patients with heart failure, and they do so without significantly altering a person's quality of life, say researchers from Duke University Medical Center.
Keeping the rhythm of life in sync
Beyond symbolically holding our feelings of love and compassion, the heart is a very efficient pump with a steady beat that provides the rhythm of life. Abnormal rhythm in the heart is a condition known as cardiac arrhythmia. A normal heart beats between 60 and 100 times per minute. It goes faster if needed for exercise or to handle emotional or physical stress.
Hidden heart condition increases the risk of death in patients waiting for kidney transplants
An often asymptomatic condition—systolic dysfunction, or decreased pumping of the heart—poses an increased risk of death for patients on kidney transplant waiting lists, according to a study appearing in the June 2008 issue of the Journal of the American Society Nephrology (JASN). The findings reveal that a clinical indicator beyond well-known risk factors for cardiovascular mortality should be considered when caring for patients waiting for kidney donations. The study also suggests that changes in organ allocation policies may be warranted.
Heart defibrillator company signs decree
The U.S. Food and Drug Administration said Medtronic Inc. has agreed to comply with FDA rules in manufacturing its external heart defibrillators.
Largest study to date finds benefits of ICDs in children
More and more children with congenital heart disease are receiving implantable cardioverter-defibrillators (ICDs) to maintain proper heart rhythm. ICDs were first introduced for adults in the 1980s, but little is known about how well they work in children, who account for less than 1 percent of recipients.
In-home AEDs don't improve sudden cardiac arrest survival
David Callans, MD, a professor of cardiovascular medicine at the University of Pennsylvania School of Medicine, will be available to comment on the New England Journal of Medicine study on the use of automated external defibrillators (AEDs) for sudden cardiac arrests that occur in the home. Callans, author of the journal editorial that accompanies the new study, serves as associate director of electrophysiology for the Penn Health System, and has extensive experience in studying ventricular arrhythmias.
iPods and similar devices found not to affect pacemaker function
Last May, a widely reported study concluded that errant electronic noise from iPods can cause implantable cardiac pacemakers to malfunction. This just didn’t sound right to the cardiac electrophysiologists at Children’s Hospital Boston, who’ve seen hundreds of children, teens and young adults with heart conditions requiring pacemakers.
Researchers Hack Defibrillators
Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits. But this convenience may come with unanticipated risks. A team of researchers from three leading universities has demonstrated that patients’ private medical information could be extracted and their devices reprogrammed without the patients’ authorization or knowledge.

News discussion:

Medicine & Health news

[Home]   [Full version]